Vaccae is lyophilized heat-killed Mycobacterium vaccae vaccine for injection indicated for treatment of patients with pulmonary tuberculosis. Vaccae was co-developed by National Institute for the Control of Drugs and Biological Products, 309 Hospital of PLA, and Anhui Longcom Biologic Pharmacy Co., Ltd.. SFDA of China approved Vaccae in January 2001. (Licence code, GuoYaoZhunZi S20010003)
Specifications
- vaccae
- Vaccae is a sterile, white to pale yellow, preservative free lyophilized powder for deep intramuscular administration
- pulmonary tuberculosis
- The immunotherapeutic effect of Mycobacterium vaccae vaccine on initially treated pulmonary tuberculosis
- MDR-TB
- Immunotherapeutic effect of Mycobacterium vaccae on multi-drug resistant pulmonary tuberculosis
Features
- supplied
- Vaccae is a sterile, white to pale yellow, preservative free lyophilized powder for deep intramuscular administration
- Storage and stability
- Vials of Vaccae must be kept in dark place under 2~8℃(36~46℉). DO NOT FREEZE
Main Products
VACCAE